HALO logo
halo search icon
XSPRAY
Xspray Pharma AB

XSPRAY · Xspray Pharma AB

10.88

SEK
-0.30 (-2.683%)
07/10/2026 12:00:00 AM
Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

kr595.55M

PE

0.00

EV/EBITDA

N/A

DIV Yield

0%

Payout Ratio

0%

MQV Rating

5Very Weak

As at 07/10/2026 12:00:00 AM

Price Chart

Description

Xspray Pharma AB is a pharmaceutical company, which develops and produces product candidates in clinical development phase. It uses its innovative, patented technology to develop amorphous product candidates that are improved versions of marketed drugs, primarily protein kinase inhibitors, for the treatment of cancer. Its product portfolio includes candidates based on the firm's HyNap platform: Dasynoc, HyNap-Nilo, and HyNap-Sora. The company was founded by Mustafa Demirbüker and Håkan Nykvist in November 2003 and is headquartered in Solna, Sweden.

  • All-Companies
  • Big Candle
  • HALO All
  • HALO Consensus Value
  • HALO Small
  • Hammer Bearish (Realtime)

Key Fundamentals

EPS 3 yr Growth

-25.80%

EBITDA Margin

N/A

Operating Cashflow

-kr193m

Free Cash Flow Return

-27.60%

ROIC

-24.50%

Interest Coverage

-9.30

Quick Ratio

7.40

Performance

52 weeks range

Low 9.06 - 61.85

Trade Value (12mth)

US$65,291.00

1 week

34.04%

1 month

24.6%

YTD

-57.44%

1 year

-78.51%

All time high

249.73

Additional Data

Shares Outstanding (Fully Diluted)

46m

HALO Sector

Healthcare

Next Company Report Date

11-Feb-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

SEK

Short Sell (% of issue)

0.00

Consensus

Lock Icon

Unlock full consensus

Consensus score

Lock Icon/10

Recommendation

Buy

Target price

Lock Icon

Deviation

Lock Icon

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Very Weak

Momentum

Price

Strong

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

Valuation

Lock Icon

Unlock full dataset

Value

Lock Icon

Consensus

Lock Icon

Yield

Lock Icon

News & Announcements

No announcements available.

Key Stakeholders

NameTitle
Flerie Invest ABSubsidiary
Anders Lennart BladhIndividual
Östersjöstiftelsen (Private Equity)Operating Division
UnionenPrivate Company
Carl Erik NormanIndividual

See beyond the curve.

One solution for research, investing and model portfolio management.
Start FREE Trial
Want to learn more?Frequently asked questions.
1
What is the current share price of Xspray Pharma AB (XSPRAY:OME)?
Halo FAQ
The current share price of Xspray Pharma AB (XSPRAY:OME) is SEKkr10.88.
2
What is the 52-week high share price for Xspray Pharma AB (XSPRAY:OME)?
Halo FAQ
The 52-week high share price for Xspray Pharma AB (XSPRAY:OME) is SEKkr61.85.
3
What is the 52-week low share price for Xspray Pharma AB (XSPRAY:OME)?
Halo FAQ
The 52-week low share price for Xspray Pharma AB (XSPRAY:OME) is SEKkr9.06.
4
What is the dividend yield for Xspray Pharma AB (XSPRAY:OME)?
Halo FAQ
Xspray Pharma AB (XSPRAY:OME) does not pay a dividend.
5
What was Xspray Pharma AB (XSPRAY:OME) last dividend payment?
Halo FAQ
Xspray Pharma AB (XSPRAY:OME) does not pay a dividend.
6
What is the franking level for Xspray Pharma AB (XSPRAY:OME)?
Halo FAQ
Xspray Pharma AB (XSPRAY:OME) has a franking level of 0.00%.
7
In which sector is Xspray Pharma AB (XSPRAY:OME) classified?
Halo FAQ
Xspray Pharma AB (XSPRAY:OME) is classified in the Healthcare.